BioAffinity Technologies

BIAFW · NASDAQ

$0.175−$0.2441 (−58.24%)TodayMarket closed ·
Prev close $0.4191

Revenue by product and region

Fiscal year ended Dec 31, 2025: $6.16M total revenue

By product

  • Histology Service Fees [Member]$1.12M1812.6%
  • Health Care, Patient Service [Member]$963.00K1562.8%
  • Medical Director Fees [Member]$68.27K110.8%
  • Other Revenues [Member]$4.86K7.9%
  • Department of Defense Observational Studies [Member]$5770.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.